Insulin Lilly Humalog Flacon solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin lilly humalog flacon solution injectable

eli lilly (suisse) sa - insulinum lisprum - solution injectable - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.5 mg. - diabète sucré - biotechnologika

Insulin Lilly Humalog cartouches 3,0 ml solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin lilly humalog cartouches 3,0 ml solution injectable

eli lilly (suisse) sa - insulinum lisprum - solution injectable - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.5 mg. - diabète sucré - biotechnologika

Insulin Lilly Humalog Mix 25 cartouches 3,0 mL suspension injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin lilly humalog mix 25 cartouches 3,0 ml suspension injectable

eli lilly (suisse) sa - insulinum lisprum - suspension injectable - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg ut insulinum solutum 25 % et insulinum isophanum 75 %, protamini sulfas, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, phenolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 1 ml corresp. natrium 0.8 mg. - diabète sucré - biotechnologika

Insulin Lilly Humalog Mix 50 cartouches 3.0 mL suspension injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin lilly humalog mix 50 cartouches 3.0 ml suspension injectable

eli lilly (suisse) sa - insulinum lisprum - suspension injectable - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg ut insulinum solutum 50 % et insulinum isophanum 50 %, protamini sulfas, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, phenolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 1 ml corresp. natrium 0.8 mg. - diabète sucré - biotechnologika

Insulin NovoNordisk NovoRapid Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u. corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg. - le diabète sucré - biotechnologika

Insulin NovoNordisk NovoRapid Penfill Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid penfill solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u. corresp. corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg. - le diabète sucré - biotechnologika

Lantus solution injectable en cartouche Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

lantus solution injectable en cartouche

sanofi-aventis (suisse) sa - insulinum glarginum - solution injectable en cartouche - insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - diabète sucré - biotechnologika

Insulin NovoNordisk NovoMix 30 Penfill Suspension injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novomix 30 penfill suspension injectable

novo nordisk pharma ag - insulinum aspartum - suspension injectable - insulinum aspartum 100 u., insulinum soluble 30 % et insulinum isophanum 70 %, protamini sulfamidés, le zinc comme zinci chloridum, glycerolum, natrii chloridum, natrii phosphates ou, conserv.: phenolum 1.50 mg, metacresolum 1,72 mg, de l'eau à iniectabilia q.s. à la suspension pour 1 ml. - le diabète sucré - biotechnologika

Insulin NovoNordisk NovoRapid FlexPen Solution injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid flexpen solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u.i., corresp. 3.5 mg, glycerolum, zinci chloridum, dinatrii phosphas dihydricus, natrii chloridum, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, phenolum, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.216 mg. - le diabète sucré - biotechnologika

Insulin NovoNordisk NovoMix 30 FlexPen Suspension injectable Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novomix 30 flexpen suspension injectable

novo nordisk pharma ag - insulinum aspartum - suspension injectable - insulinum aspartum 100 u., insulinum soluble 30 % et insulinum isophanum 70 %, protamini sulfamidés, le zinc comme zinci chloridum, glycerolum, natrii chloridum, natrii phosphates ou, conserv.: phenolum 1.50 mg, metacresolum 1,72 mg, de l'eau à iniectabilia q.s. à la suspension pour 1 ml. - le diabète sucré - biotechnologika